Search by Drug Name or NDC

NDC 42708-0034-30 Lisinopril and Hydrochlorothiazide 12.5; 10 mg/1; mg/1 Details

Lisinopril and Hydrochlorothiazide 12.5; 10 mg/1; mg/1

Lisinopril and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by QPharma Inc. The primary component is HYDROCHLOROTHIAZIDE; LISINOPRIL.

MedlinePlus Drug Summary

The combination of lisinopril and hydrochlorothiazide is used to treat high blood pressure. Lisinopril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels, so blood flows more smoothly. Hydrochlorothiazide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Related Packages: 42708-0034-30
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lisinopril and Hydrochlorothiazide

Product Information

NDC	42708-0034
Product ID	42708-034_f27b52ee-982d-0947-e053-2a95a90a1e53
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Lisinopril and Hydrochlorothiazide
Proprietary Name Suffix	n/a
Non-Proprietary Name	Lisinopril and Hydrochlorothiazide
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	12.5; 10
Active Ingredient Units	mg/1; mg/1
Substance Name	HYDROCHLOROTHIAZIDE; LISINOPRIL
Labeler Name	QPharma Inc
Pharmaceutical Class	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA076194
Listing Certified Through	2024-12-31

Package

NDC 42708-0034-30 (42708003430)

Pricing Information	N/A
NDC Package Code	42708-034-30
Billing NDC	42708003430
Package	30 TABLET in 1 BOTTLE, PLASTIC (42708-034-30)
Marketing Start Date	2018-03-29
NDC Exclude Flag	N